5 assets in Neoplasm Of Mature T-Cells Or NK-Cells

Therapeutic assets addressing Neoplasm Of Mature T-Cells Or NK-Cells, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Autologous Ccr4 Car T Cells Neoplasm Of Mature T-Cells Or NK-Cells	National Cancer Institute (NCI)	P1	CC (43)
Cyclophosphamide Neoplasm Of Mature T-Cells Or NK-Cells	National Cancer Institute (NCI)	P1	CC (43)
Duvelisib Neoplasm Of Mature T-Cells Or NK-Cells	Memorial Sloan Kettering Cancer Center	P1	CC (43)
Fludarabine Neoplasm Of Mature T-Cells Or NK-Cells	National Cancer Institute (NCI)	P1	CC (43)
Ruxolitinib Neoplasm Of Mature T-Cells Or NK-Cells	Memorial Sloan Kettering Cancer Center	P1	CC (43)